Evidence map›Paper›PMID 31921203›Full record

ArticleFrontiers in immunology2019

Two Different Missense

Isabelle Bally, Fabien Dalonneau, Anne Chouquet, Rebekka Gröbner, Albert Amberger, Ines Kapferer-Seebacher, Heribert Stoiber, Johannes Zschocke, Nicole M Thielens, Véronique Rossi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Isabelle BallyUniversity Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Fabien DalonneauUniversity Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Anne ChouquetUniversity Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Rebekka GröbnerDivision of Human Genetics, Institute of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.
Albert AmbergerDivision of Human Genetics, Institute of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.
Ines Kapferer-SeebacherDepartment for Operative and Restorative Dentistry, Medical University Innsbruck, Innsbruck, Austria.
Heribert StoiberInstitute of Virology, Medical University Innsbruck, Innsbruck, Austria.
Johannes ZschockeDivision of Human Genetics, Institute of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.
Nicole M ThielensUniversity Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Véronique RossiUniversity Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Christine GaboriaudUniversity Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Innsbruck Medical University · ATCEA Grenoble · FRCentre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInstitut de Biologie Structurale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ehlers-Danlos syndromes (EDS) are clinically and genetically heterogeneous disorders characterized by soft connective tissue alteration like joint hypermobility and skin hyper-extensibility. We previously identified heterozygous missense mutations in the

Indexed as

Complement C1rComplement C1sEhlers-Danlos SyndromeMutation, MissensePeriodontal DiseasesAmino Acid SubstitutionHEK293 CellsHumansProtein FoldingComplement C1rComplement C1sC1s proteasecomplement systemEhlers-DanlosHMGB1periodontal

Identifiers

PMID31921203
PMCPMC6930149
OpenAlexW2995422230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.